Bioxodes reports promising Phase 2a clinical results for innovative stroke candidate BIOX-101 Bioxodes, an innovative biotech company member of BioPark Charleroi, has reported positive Phase 2a clinical results for its innovative therapeutic candidate BIOX-101, developed for the treatment of i... Bioxodes Funding